RHCE antibody (FITC)
- Known as:
- RHCE (anti-) (fluorecein)
- Catalog number:
- orb103378
- Product Quantity:
- EUR
- Category:
- -
- Supplier:
- Biorbyt biorb
- Gene target:
- RHCE antibody (FITC)
Ask about this productRelated genes to: RHCE antibody (FITC)
- Gene:
- RHCE NIH gene
- Name:
- Rh blood group CcEe antigens
- Previous symbol:
- RH
- Synonyms:
- CD240CE
- Chromosome:
- 1p36.11
- Locus Type:
- gene with protein product
- Date approved:
- 1993-10-22
- Date modifiied:
- 2019-04-23
Related products to: RHCE antibody (FITC)
Related articles to: RHCE antibody (FITC)
- While the previous review encompassed the Rh blood group system (Chou ST, Westhoff CM. The Rh and RhAG blood group systems. . 2010;26:178-86), this update focusses on the gene and its variants. Four new antigens- PARG, CEVF, CEWA, and CETW (RH60 to RH63)-were reported since the last update. ) was amended from a null allele to an allele encoding very weak antigen expression. The following topics are discussed: cross-reactive alleles [such as (*) and * (*) which may type D+ with some monoclonal anti-D reagents], issues with hybrid alleles and allele dropout, common haplotypes (association between alleles and specific alleles), and clinical considerations. While the detailed description of new Rh antigens has become rare, many alleles have been reported since the previous review, a result of increased adoption of DNAbased testing for red blood cell antigens in immunohematology laboratories. The Rh blood group system has fascinated generations of immunohematologists and is likely to continue to do so for decades to come. - Source: PubMed
Publication date: 2026/07/23
Floch AlineTournamille ChristopheVege Sunitha - The D- - phenotype is an exceptionally rare Rh configuration characterised by the expression of the D antigen but absence of all RHCE-encoded antigens. A few molecularly defined cases have been documented globally. - Source: PubMed
Publication date: 2026/07/03
Madkhali Maymoon MMeshi Abdullah AOsman MahdiAlnefaie AbdulrahmanAlmalky HosainKhormy MayisahGhazwani KhaledHamali Hassan AStef Marianne - This study aimed to validate the efficacy of right-heart contrast echocardiography (RHCE) combined with the Valsalva manoeuvre for screening for patent foramen ovale (PFO) in patients with migraine without an identified secondary cause. - Source: PubMed
Gu HaijuanXia JieshengXu ZhenhuaShi Jianwei - The CeRN (RHCE*02.10) allele was described as resulting from hybrid RHCE-D-CE genes, involving either exon 4 alone or exon 4 and part of exon 3. No solution allows to distinguish between the two reported CeRN alleles. The objectives of this study were to determine the existence of both alleles, their genetic sequence and their frequencies. - Source: PubMed
Publication date: 2026/05/29
Hadjkali AssiaIzard CarolineLaget LaurineDe Boisgrollier LugdivineBichel NellyDeligny Marie-LaurenceMazières StéphaneGalloux MélissaPaganini JulienChiaroni JacquesDi Cristofaro Julie - The Rh blood group system includes several compound antigens, among which the f antigen (ISBT 004006) is expressed when the c and e antigens occur in cis position on the same RhCE protein. Anti-f is a rare alloantibody but is clinically significant due to its potential to cause hemolytic transfusion reactions and hemolytic disease of the newborn. We report a rare case of anti-f with coexisting anti-c identified during pre-transfusion testing in a 40-year-old female admitted for elective hysterectomy. Her blood group was O Rh D positive and her antibody screen was positive with a negative autocontrol and direct antiglobulin test. Extended phenotyping revealed CCee, K-negative phenotype. Antibody identification using an 11-cell panel suggested anti-c and anti-f, which was further confirmed by allogeneic adsorption studies using Rh-phenotyped donor cells. During cross-matching, only R1R1 units were found to be compatible. This case highlights the importance of extended Rh phenotyping, adsorption studies, and careful selection of compatible donor units in resolving rare Rh antibody combinations to ensure safe transfusions to patients. - Source: PubMed
Publication date: 2026/05/28
Kakkar BrindaBaldota RutujaGokhale AshaKetkar SanjivChavan MinakshiKeripale Amruta